-
13 States Working Towards Smart, Sane Marijuana Laws
Sign up to stay up to date on the latest Drugs headlines via email.
State legislatures have convened or are convening all around the country, and once again this year, marijuana decriminalization or legalization are hot topics at the statehouse. Legalization bills are pending in three states (as well as on the ballot as initiatives in Washington and almost certainly Colorado), decriminalization bills are alive in nine states, and bills that would improve existing decriminalization laws have been filed in two states.
And this is still early in the legislative season. Bills can still be introduced in many states, and bills that have already been introduced can advance or be killed. By around the beginning of May, a clearer picture should emerge, but 2012 is already looking to be even more active than last year when it comes to decriminalization and legalization bills.
There's a reason for that, said leading reformers.
"We're seeing more bills introduced, and they're having stronger and more sponsors," said Karen O'Keefe, state policy director for the Marijuana Policy Project (MPP). "We're also seeing more and more public support for decriminalization and legalization. We're approaching critical mass as more and more people see marijuana prohibition as a failed public policy, and in legislatures because of fiscal constraints and changing public sentiment."
"Each year, these bills are easier to introduce, there is less controversy, and the media reaction is generally neutral to positive," said Allen St. Pierre, executive director of NORML. "Baby boomers, medical marijuana, the Internet, and the state of the economy have all had an impact, even, finally, on legislators and their staffs," he explained.
"Before 1996, nobody invited NORML; now our staff is regularly going to meetings requested by legislators around the country," St. Pierre recalled. "First, we couldn't get them to return our phone calls; now they're calling us. Everything is in play because of activists around the country doing years of work."
That contact with legislators has led to results, St. Pierre said. "We've been involved in almost all of this legislation. Either we helped write it or legislators contacted us for deep background and we're testifying at public hearings on these bills."
MPP has been busy, too, O'Keefe said. "We have paid lobbyists in Rhode Island and Vermont, and one of our legislative analysts, Matt Simon, is from New Hampshire and has been working on bills up there," she said.
Perhaps not surprisingly, O'Keefe thought the prospects of passage were best in Rhode Island and Vermont. "In Rhode Island, more than half of both chambers are cosponsors of the decriminalization bill, while in Vermont, Gov. Shumlin has been very supportive, and for the first time we have a Republican sponsor in the Senate -- we already had one in the House," she said.
Getting a marijuana bill through a state legislature is a frustrating, time-consuming process, and there is a chance that none of these bills will pass this year. But there is also a chance some will, and some will pass eventually, if not this year, next year, or the year after.
Here is what is currently going on around marijuana law reform at the state house (compiled from our Legislative Center, with additional information from MPP's list of bills and from cantaxreg.com):
Legalization Bills
Massachusetts
Thirteen months ago, Rep. Ellen Story introduced House Bill 1371, which would allow the legal and regulated sale of marijuana to adults. It was referred to the Joint Committee on Judiciary then, and it is still pending. A hearing is scheduled on March 6.
New Hampshire
Last month, Rep. Calvin Pratt (R) introduced HB 1705, which would allow people 21 and over to possess up to an ounce and allow for regulated retail and wholesale sales. Marijuana would be taxed at a rate of $45 an ounce at wholesale and at 19% of the wholesale price at retail. The bill is now before the House Criminal Justice and Public Safety Committee.
Stay up to date with the latest Drugs headlines via email






